Page last updated: 2024-08-26

bosentan anhydrous and Cardiomyopathies, Primary

bosentan anhydrous has been researched along with Cardiomyopathies, Primary in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Belloni, AS; Kreutz, R; Nussdorfer, GG; Paul, M; Pessina, AC; Rossi, GP; Seccia, TM	1
Bien, S; Ciecholewski, S; Ewert, R; Felix, SB; Gratz, M; Grube, M; Krieg, T; Kroemer, HK; Olshausen, F; Riad, A; Ritter, CA; Schultheiss, HP; Staudt, A; Tschöpe, C; Völker, U; Westermann, D	1

Other Studies

2 other study(ies) available for bosentan anhydrous and Cardiomyopathies, Primary

Article	Year
Cardiac fibrosis occurs early and involves endothelin and AT-1 receptors in hypertension due to endogenous angiotensin II. Journal of the American College of Cardiology, 2003, Feb-19, Volume: 41, Issue:4 Topics: Angiotensin II; Animals; Animals, Genetically Modified; Antihypertensive Agents; Biphenyl Compounds; Bosentan; Cardiomyopathies; Dansyl Compounds; Disease Models, Animal; Endothelin-1; Fibrosis; Hypertension; Irbesartan; Male; Rats; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Receptors, Cell Surface; Sulfonamides; Tetrazoles; Time Factors; Vasoconstrictor Agents	2003
The endothelin receptor blocker bosentan inhibits doxorubicin-induced cardiomyopathy. Cancer research, 2007, Nov-01, Volume: 67, Issue:21 Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Bosentan; Cardiomyopathies; Doxorubicin; Endothelin-1; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; GATA4 Transcription Factor; Lipid Peroxidation; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Mice; Mice, Inbred C57BL; Rats; Sulfonamides; Tumor Necrosis Factor-alpha; Ventricular Function, Left	2007

Article

Year

Cardiac fibrosis occurs early and involves endothelin and AT-1 receptors in hypertension due to endogenous angiotensin II.

Journal of the American College of Cardiology, 2003, Feb-19, Volume: 41, Issue:4

Topics: Angiotensin II; Animals; Animals, Genetically Modified; Antihypertensive Agents; Biphenyl Compounds; Bosentan; Cardiomyopathies; Dansyl Compounds; Disease Models, Animal; Endothelin-1; Fibrosis; Hypertension; Irbesartan; Male; Rats; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Receptors, Cell Surface; Sulfonamides; Tetrazoles; Time Factors; Vasoconstrictor Agents

2003

The endothelin receptor blocker bosentan inhibits doxorubicin-induced cardiomyopathy.

Cancer research, 2007, Nov-01, Volume: 67, Issue:21

Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Bosentan; Cardiomyopathies; Doxorubicin; Endothelin-1; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; GATA4 Transcription Factor; Lipid Peroxidation; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Mice; Mice, Inbred C57BL; Rats; Sulfonamides; Tumor Necrosis Factor-alpha; Ventricular Function, Left

2007